Yi-Mei Hung Selected Research

2,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanone

7/2004

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Mei Hung Research Topics

Disease

6	Neoplasms (Cancer) 01/2013 - 02/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2015
2	Lung Neoplasms (Lung Cancer) 10/2015 - 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Inflammation (Inflammations) 05/2009
1	Carcinoma (Carcinomatosis) 02/2005
1	Pleural Effusion (Pleural Effusions) 02/2005
1	Malignant Pleural Effusion 02/2005
1	Necrosis 07/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2004
1	Colorectal Neoplasms (Colorectal Cancer) 04/2004
1	Colonic Neoplasms (Colon Cancer) 04/2004
1	Glioma (Gliomas) 03/2004
1	Glioblastoma (Glioblastoma Multiforme) 03/2004
1	Pheochromocytoma 01/2004
1	Nasopharyngeal Carcinoma 01/2004
1	Leukemia 01/2004

Drug/Important Bio-Agent (IBA)

2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2004
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
2	Phosphopyruvate Hydratase (Enolase)IBA 10/2015 - 01/2013
2	Cancer VaccinesIBA 05/2009 - 02/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 02/2005 - 02/2004
2	CaspasesIBA 07/2004 - 04/2004
2	LigandsIBA 03/2004 - 01/2004
1	AntibodiesIBA 10/2015
1	PlasminogenIBA 01/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2013
1	VaccinesIBA 05/2009
1	ChemokinesIBA 05/2009
1	Propidium (Propidium Iodide)IBA 07/2004
1	2,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanoneIBA 07/2004
1	Annexin A5IBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004
1	HLA-A*02:01 antigenIBA 04/2004
1	Carcinoembryonic AntigenIBA 04/2004
1	Peptides (Polypeptides)IBA 04/2004
1	HLA-A Antigens (HLA-A)IBA 04/2004
1	Interferon-betaIBA 04/2004
1	Epidermal Growth Factor (EGF)IBA 03/2004
1	AntigensIBA 02/2004
1	CD40 Ligand (CD40L)IBA 02/2004
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2004
1	3,3'-diethyloxadicarbocyanineIBA 01/2004

Therapy/Procedure

3	Therapeutics 01/2020 - 03/2004
1	Drug Therapy (Chemotherapy) 04/2004
1	Aftercare (After-Treatment) 04/2004